Davide V Moretti Selected Research

Biomarkers (Surrogate Marker)

1/2020	Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study.
1/2019	Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.
1/2016	Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia.
1/2013	Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio.
12/2012	Analysis of grey matter in thalamus and basal ganglia based on EEG α3/α2 frequency ratio reveals specific changes in subjects with mild cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davide V Moretti Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 07/2006
4	Dementia (Dementias) 01/2020 - 12/2012
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2016 - 03/2009
1	Cognitive Dysfunction 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2015

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2012
2	ProgranulinsIBA 01/2016 - 03/2009
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2014 - 01/2014
1	rotigotine FDA Link 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2006
1	Cholinergic Agents (Cholinergics)IBA 07/2006
1	Donepezil (Aricept)FDA LinkGeneric 07/2006

Therapy/Procedure

1	Deep Brain Stimulation 01/2015